nodes	percent_of_prediction	percent_of_DWPC	metapath
Gatifloxacin—ALB—hematologic cancer	0.413	1	CbGaD
Gatifloxacin—ALB—Imatinib—hematologic cancer	0.0773	0.383	CbGbCtD
Gatifloxacin—ALB—Prednisone—hematologic cancer	0.051	0.252	CbGbCtD
Gatifloxacin—ALB—Irinotecan—hematologic cancer	0.0483	0.239	CbGbCtD
Gatifloxacin—ALB—Methotrexate—hematologic cancer	0.0256	0.126	CbGbCtD
Gatifloxacin—Moxifloxacin—TOP2A—hematologic cancer	0.00122	0.177	CrCbGaD
Gatifloxacin—Pefloxacin—TOP2A—hematologic cancer	0.000889	0.129	CrCbGaD
Gatifloxacin—Enoxacin—TOP2A—hematologic cancer	0.000831	0.121	CrCbGaD
Gatifloxacin—Sparfloxacin—TOP2A—hematologic cancer	0.000765	0.111	CrCbGaD
Gatifloxacin—Lomefloxacin—TOP2A—hematologic cancer	0.00063	0.0915	CrCbGaD
Gatifloxacin—Levofloxacin—TOP2A—hematologic cancer	0.000538	0.0782	CrCbGaD
Gatifloxacin—Ofloxacin—TOP2A—hematologic cancer	0.000538	0.0782	CrCbGaD
Gatifloxacin—Ciprofloxacin—TOP2A—hematologic cancer	0.00052	0.0755	CrCbGaD
Gatifloxacin—Norfloxacin—TOP2A—hematologic cancer	0.000437	0.0634	CrCbGaD
Gatifloxacin—Sparfloxacin—ABCB1—hematologic cancer	0.000218	0.0316	CrCbGaD
Gatifloxacin—Levofloxacin—ABCB1—hematologic cancer	0.000153	0.0222	CrCbGaD
Gatifloxacin—Ciprofloxacin—ABCB1—hematologic cancer	0.000148	0.0215	CrCbGaD
Gatifloxacin—ALB—Vitamin B12 Metabolism—CRP—hematologic cancer	4.72e-05	0.0057	CbGpPWpGaD
Gatifloxacin—ALB—Folate Metabolism—SOD2—hematologic cancer	4.58e-05	0.00554	CbGpPWpGaD
Gatifloxacin—ALB—FOXA2 and FOXA3 transcription factor networks—CREB1—hematologic cancer	4.46e-05	0.0054	CbGpPWpGaD
Gatifloxacin—ALB—Folate Metabolism—IL4—hematologic cancer	4.44e-05	0.00537	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—CD2—hematologic cancer	4.36e-05	0.00528	CbGpPWpGaD
Gatifloxacin—ALB—Vitamin B12 Metabolism—ICAM1—hematologic cancer	4.34e-05	0.00524	CbGpPWpGaD
Gatifloxacin—ALB—Platelet degranulation—PDGFA—hematologic cancer	4.32e-05	0.00522	CbGpPWpGaD
Gatifloxacin—ALB—SLC-mediated transmembrane transport—SLC26A4—hematologic cancer	4.27e-05	0.00516	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—GNA13—hematologic cancer	4.13e-05	0.005	CbGpPWpGaD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—PDGFA—hematologic cancer	4.12e-05	0.00498	CbGpPWpGaD
Gatifloxacin—Dermatitis—Gemcitabine—hematologic cancer	4.07e-05	0.00011	CcSEcCtD
Gatifloxacin—Eye disorder—Epirubicin—hematologic cancer	4.06e-05	0.00011	CcSEcCtD
Gatifloxacin—Hypersensitivity—Etoposide—hematologic cancer	4.06e-05	0.00011	CcSEcCtD
Gatifloxacin—Tinnitus—Epirubicin—hematologic cancer	4.05e-05	0.00011	CcSEcCtD
Gatifloxacin—Erythema—Methotrexate—hematologic cancer	4.04e-05	0.000109	CcSEcCtD
Gatifloxacin—Headache—Gemcitabine—hematologic cancer	4.04e-05	0.000109	CcSEcCtD
Gatifloxacin—Nausea—Vincristine—hematologic cancer	4.04e-05	0.000109	CcSEcCtD
Gatifloxacin—ALB—Folate Metabolism—MTHFR—hematologic cancer	4.03e-05	0.00488	CbGpPWpGaD
Gatifloxacin—Hepatitis—Doxorubicin—hematologic cancer	4.02e-05	0.000109	CcSEcCtD
Gatifloxacin—Hypersensitivity—Prednisolone—hematologic cancer	4e-05	0.000108	CcSEcCtD
Gatifloxacin—Pharyngitis—Doxorubicin—hematologic cancer	3.99e-05	0.000108	CcSEcCtD
Gatifloxacin—Dyspepsia—Dexamethasone—hematologic cancer	3.99e-05	0.000108	CcSEcCtD
Gatifloxacin—Dyspepsia—Betamethasone—hematologic cancer	3.99e-05	0.000108	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—PHYH—hematologic cancer	3.97e-05	0.0048	CbGpPWpGaD
Gatifloxacin—Urticaria—Triamcinolone—hematologic cancer	3.97e-05	0.000107	CcSEcCtD
Gatifloxacin—Oedema peripheral—Doxorubicin—hematologic cancer	3.96e-05	0.000107	CcSEcCtD
Gatifloxacin—Dysgeusia—Methotrexate—hematologic cancer	3.96e-05	0.000107	CcSEcCtD
Gatifloxacin—Asthenia—Etoposide—hematologic cancer	3.95e-05	0.000107	CcSEcCtD
Gatifloxacin—Body temperature increased—Triamcinolone—hematologic cancer	3.95e-05	0.000107	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Prednisone—hematologic cancer	3.95e-05	0.000107	CcSEcCtD
Gatifloxacin—Oedema—Prednisone—hematologic cancer	3.95e-05	0.000107	CcSEcCtD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—JAK3—hematologic cancer	3.94e-05	0.00477	CbGpPWpGaD
Gatifloxacin—Decreased appetite—Betamethasone—hematologic cancer	3.94e-05	0.000107	CcSEcCtD
Gatifloxacin—Decreased appetite—Dexamethasone—hematologic cancer	3.94e-05	0.000107	CcSEcCtD
Gatifloxacin—Nausea—Irinotecan—hematologic cancer	3.94e-05	0.000106	CcSEcCtD
Gatifloxacin—Nausea—Mitoxantrone—hematologic cancer	3.94e-05	0.000106	CcSEcCtD
Gatifloxacin—Infection—Prednisone—hematologic cancer	3.92e-05	0.000106	CcSEcCtD
Gatifloxacin—ALB—Platelet degranulation—HGF—hematologic cancer	3.91e-05	0.00473	CbGpPWpGaD
Gatifloxacin—Back pain—Methotrexate—hematologic cancer	3.91e-05	0.000106	CcSEcCtD
Gatifloxacin—Chills—Epirubicin—hematologic cancer	3.9e-05	0.000105	CcSEcCtD
Gatifloxacin—Pruritus—Etoposide—hematologic cancer	3.9e-05	0.000105	CcSEcCtD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—CD9—hematologic cancer	3.89e-05	0.0047	CbGpPWpGaD
Gatifloxacin—Shock—Prednisone—hematologic cancer	3.89e-05	0.000105	CcSEcCtD
Gatifloxacin—ALB—Vitamin B12 Metabolism—CCL2—hematologic cancer	3.88e-05	0.00469	CbGpPWpGaD
Gatifloxacin—Visual impairment—Doxorubicin—hematologic cancer	3.88e-05	0.000105	CcSEcCtD
Gatifloxacin—Tachycardia—Prednisone—hematologic cancer	3.85e-05	0.000104	CcSEcCtD
Gatifloxacin—ALB—Folate Metabolism—CRP—hematologic cancer	3.84e-05	0.00464	CbGpPWpGaD
Gatifloxacin—Nausea—Gemcitabine—hematologic cancer	3.83e-05	0.000104	CcSEcCtD
Gatifloxacin—Vomiting—Cisplatin—hematologic cancer	3.82e-05	0.000103	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Prednisone—hematologic cancer	3.82e-05	0.000103	CcSEcCtD
Gatifloxacin—Vision blurred—Methotrexate—hematologic cancer	3.81e-05	0.000103	CcSEcCtD
Gatifloxacin—Erythema multiforme—Doxorubicin—hematologic cancer	3.8e-05	0.000103	CcSEcCtD
Gatifloxacin—Rash—Cisplatin—hematologic cancer	3.79e-05	0.000103	CcSEcCtD
Gatifloxacin—Dermatitis—Cisplatin—hematologic cancer	3.79e-05	0.000102	CcSEcCtD
Gatifloxacin—Erythema—Epirubicin—hematologic cancer	3.79e-05	0.000102	CcSEcCtD
Gatifloxacin—Diarrhoea—Etoposide—hematologic cancer	3.77e-05	0.000102	CcSEcCtD
Gatifloxacin—Anorexia—Prednisone—hematologic cancer	3.77e-05	0.000102	CcSEcCtD
Gatifloxacin—Eye disorder—Doxorubicin—hematologic cancer	3.76e-05	0.000102	CcSEcCtD
Gatifloxacin—Tinnitus—Doxorubicin—hematologic cancer	3.75e-05	0.000101	CcSEcCtD
Gatifloxacin—Feeling abnormal—Dexamethasone—hematologic cancer	3.74e-05	0.000101	CcSEcCtD
Gatifloxacin—Feeling abnormal—Betamethasone—hematologic cancer	3.74e-05	0.000101	CcSEcCtD
Gatifloxacin—Flatulence—Epirubicin—hematologic cancer	3.73e-05	0.000101	CcSEcCtD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—HGF—hematologic cancer	3.73e-05	0.00451	CbGpPWpGaD
Gatifloxacin—Tension—Epirubicin—hematologic cancer	3.71e-05	0.0001	CcSEcCtD
Gatifloxacin—ALB—Hemostasis—CD58—hematologic cancer	3.71e-05	0.00449	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—THPO—hematologic cancer	3.71e-05	0.00449	CbGpPWpGaD
Gatifloxacin—Gastrointestinal pain—Dexamethasone—hematologic cancer	3.71e-05	0.0001	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Betamethasone—hematologic cancer	3.71e-05	0.0001	CcSEcCtD
Gatifloxacin—Dysgeusia—Epirubicin—hematologic cancer	3.71e-05	0.0001	CcSEcCtD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—IL3RA—hematologic cancer	3.68e-05	0.00445	CbGpPWpGaD
Gatifloxacin—Hypersensitivity—Triamcinolone—hematologic cancer	3.68e-05	9.96e-05	CcSEcCtD
Gatifloxacin—Nervousness—Epirubicin—hematologic cancer	3.68e-05	9.94e-05	CcSEcCtD
Gatifloxacin—Back pain—Epirubicin—hematologic cancer	3.66e-05	9.9e-05	CcSEcCtD
Gatifloxacin—Dizziness—Etoposide—hematologic cancer	3.64e-05	9.85e-05	CcSEcCtD
Gatifloxacin—ALB—Selenium Micronutrient Network—SOD2—hematologic cancer	3.64e-05	0.0044	CbGpPWpGaD
Gatifloxacin—Muscle spasms—Epirubicin—hematologic cancer	3.64e-05	9.84e-05	CcSEcCtD
Gatifloxacin—Vertigo—Methotrexate—hematologic cancer	3.63e-05	9.83e-05	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—SMPD3—hematologic cancer	3.63e-05	0.00439	CbGpPWpGaD
Gatifloxacin—Chills—Doxorubicin—hematologic cancer	3.61e-05	9.76e-05	CcSEcCtD
Gatifloxacin—Urticaria—Dexamethasone—hematologic cancer	3.6e-05	9.74e-05	CcSEcCtD
Gatifloxacin—Urticaria—Betamethasone—hematologic cancer	3.6e-05	9.74e-05	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Prednisone—hematologic cancer	3.6e-05	9.73e-05	CcSEcCtD
Gatifloxacin—Dizziness—Prednisolone—hematologic cancer	3.59e-05	9.72e-05	CcSEcCtD
Gatifloxacin—Asthenia—Triamcinolone—hematologic cancer	3.59e-05	9.7e-05	CcSEcCtD
Gatifloxacin—Body temperature increased—Dexamethasone—hematologic cancer	3.59e-05	9.69e-05	CcSEcCtD
Gatifloxacin—Abdominal pain—Dexamethasone—hematologic cancer	3.59e-05	9.69e-05	CcSEcCtD
Gatifloxacin—Abdominal pain—Betamethasone—hematologic cancer	3.59e-05	9.69e-05	CcSEcCtD
Gatifloxacin—Body temperature increased—Betamethasone—hematologic cancer	3.59e-05	9.69e-05	CcSEcCtD
Gatifloxacin—Nausea—Cisplatin—hematologic cancer	3.57e-05	9.66e-05	CcSEcCtD
Gatifloxacin—Insomnia—Prednisone—hematologic cancer	3.57e-05	9.66e-05	CcSEcCtD
Gatifloxacin—Vision blurred—Epirubicin—hematologic cancer	3.57e-05	9.65e-05	CcSEcCtD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—PRKCG—hematologic cancer	3.56e-05	0.0043	CbGpPWpGaD
Gatifloxacin—Paraesthesia—Prednisone—hematologic cancer	3.55e-05	9.59e-05	CcSEcCtD
Gatifloxacin—Pruritus—Triamcinolone—hematologic cancer	3.54e-05	9.56e-05	CcSEcCtD
Gatifloxacin—ALB—Folate Metabolism—ICAM1—hematologic cancer	3.53e-05	0.00427	CbGpPWpGaD
Gatifloxacin—Convulsion—Methotrexate—hematologic cancer	3.5e-05	9.48e-05	CcSEcCtD
Gatifloxacin—Vomiting—Etoposide—hematologic cancer	3.5e-05	9.47e-05	CcSEcCtD
Gatifloxacin—Erythema—Doxorubicin—hematologic cancer	3.5e-05	9.47e-05	CcSEcCtD
Gatifloxacin—Agitation—Epirubicin—hematologic cancer	3.48e-05	9.41e-05	CcSEcCtD
Gatifloxacin—Dyspepsia—Prednisone—hematologic cancer	3.48e-05	9.4e-05	CcSEcCtD
Gatifloxacin—Rash—Etoposide—hematologic cancer	3.47e-05	9.4e-05	CcSEcCtD
Gatifloxacin—Dermatitis—Etoposide—hematologic cancer	3.47e-05	9.39e-05	CcSEcCtD
Gatifloxacin—ALB—Transmembrane transport of small molecules—AQP9—hematologic cancer	3.45e-05	0.00418	CbGpPWpGaD
Gatifloxacin—Headache—Etoposide—hematologic cancer	3.45e-05	9.34e-05	CcSEcCtD
Gatifloxacin—Flatulence—Doxorubicin—hematologic cancer	3.45e-05	9.33e-05	CcSEcCtD
Gatifloxacin—Chest pain—Methotrexate—hematologic cancer	3.44e-05	9.31e-05	CcSEcCtD
Gatifloxacin—Myalgia—Methotrexate—hematologic cancer	3.44e-05	9.31e-05	CcSEcCtD
Gatifloxacin—Arthralgia—Methotrexate—hematologic cancer	3.44e-05	9.31e-05	CcSEcCtD
Gatifloxacin—Tension—Doxorubicin—hematologic cancer	3.44e-05	9.29e-05	CcSEcCtD
Gatifloxacin—Decreased appetite—Prednisone—hematologic cancer	3.43e-05	9.28e-05	CcSEcCtD
Gatifloxacin—Dysgeusia—Doxorubicin—hematologic cancer	3.43e-05	9.27e-05	CcSEcCtD
Gatifloxacin—Rash—Prednisolone—hematologic cancer	3.43e-05	9.27e-05	CcSEcCtD
Gatifloxacin—Dermatitis—Prednisolone—hematologic cancer	3.42e-05	9.26e-05	CcSEcCtD
Gatifloxacin—Headache—Prednisolone—hematologic cancer	3.41e-05	9.21e-05	CcSEcCtD
Gatifloxacin—Nervousness—Doxorubicin—hematologic cancer	3.4e-05	9.2e-05	CcSEcCtD
Gatifloxacin—Vertigo—Epirubicin—hematologic cancer	3.4e-05	9.2e-05	CcSEcCtD
Gatifloxacin—Syncope—Epirubicin—hematologic cancer	3.39e-05	9.18e-05	CcSEcCtD
Gatifloxacin—Back pain—Doxorubicin—hematologic cancer	3.39e-05	9.16e-05	CcSEcCtD
Gatifloxacin—Constipation—Prednisone—hematologic cancer	3.38e-05	9.13e-05	CcSEcCtD
Gatifloxacin—Muscle spasms—Doxorubicin—hematologic cancer	3.37e-05	9.1e-05	CcSEcCtD
Gatifloxacin—ALB—Platelet degranulation—PDGFB—hematologic cancer	3.37e-05	0.00407	CbGpPWpGaD
Gatifloxacin—Palpitations—Epirubicin—hematologic cancer	3.34e-05	9.04e-05	CcSEcCtD
Gatifloxacin—Confusional state—Methotrexate—hematologic cancer	3.33e-05	9e-05	CcSEcCtD
Gatifloxacin—Loss of consciousness—Epirubicin—hematologic cancer	3.33e-05	9e-05	CcSEcCtD
Gatifloxacin—ALB—Hemostasis—SRGN—hematologic cancer	3.31e-05	0.004	CbGpPWpGaD
Gatifloxacin—Dizziness—Triamcinolone—hematologic cancer	3.31e-05	8.94e-05	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Methotrexate—hematologic cancer	3.3e-05	8.93e-05	CcSEcCtD
Gatifloxacin—Vision blurred—Doxorubicin—hematologic cancer	3.3e-05	8.92e-05	CcSEcCtD
Gatifloxacin—ALB—Vitamin B12 Metabolism—IFNG—hematologic cancer	3.3e-05	0.00399	CbGpPWpGaD
Gatifloxacin—Convulsion—Epirubicin—hematologic cancer	3.28e-05	8.87e-05	CcSEcCtD
Gatifloxacin—Infection—Methotrexate—hematologic cancer	3.28e-05	8.87e-05	CcSEcCtD
Gatifloxacin—Nausea—Etoposide—hematologic cancer	3.27e-05	8.85e-05	CcSEcCtD
Gatifloxacin—Hypertension—Epirubicin—hematologic cancer	3.27e-05	8.84e-05	CcSEcCtD
Gatifloxacin—Feeling abnormal—Prednisone—hematologic cancer	3.25e-05	8.8e-05	CcSEcCtD
Gatifloxacin—Asthenia—Dexamethasone—hematologic cancer	3.25e-05	8.8e-05	CcSEcCtD
Gatifloxacin—Asthenia—Betamethasone—hematologic cancer	3.25e-05	8.8e-05	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Methotrexate—hematologic cancer	3.23e-05	8.74e-05	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Prednisone—hematologic cancer	3.23e-05	8.73e-05	CcSEcCtD
Gatifloxacin—Nausea—Prednisolone—hematologic cancer	3.23e-05	8.73e-05	CcSEcCtD
Gatifloxacin—Arthralgia—Epirubicin—hematologic cancer	3.22e-05	8.71e-05	CcSEcCtD
Gatifloxacin—Myalgia—Epirubicin—hematologic cancer	3.22e-05	8.71e-05	CcSEcCtD
Gatifloxacin—Chest pain—Epirubicin—hematologic cancer	3.22e-05	8.71e-05	CcSEcCtD
Gatifloxacin—Agitation—Doxorubicin—hematologic cancer	3.22e-05	8.7e-05	CcSEcCtD
Gatifloxacin—ALB—Transmembrane transport of small molecules—FXYD6—hematologic cancer	3.21e-05	0.00388	CbGpPWpGaD
Gatifloxacin—Anxiety—Epirubicin—hematologic cancer	3.21e-05	8.68e-05	CcSEcCtD
Gatifloxacin—Pruritus—Dexamethasone—hematologic cancer	3.21e-05	8.68e-05	CcSEcCtD
Gatifloxacin—Pruritus—Betamethasone—hematologic cancer	3.21e-05	8.68e-05	CcSEcCtD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—PDGFB—hematologic cancer	3.21e-05	0.00388	CbGpPWpGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—MTHFR—hematologic cancer	3.2e-05	0.00387	CbGpPWpGaD
Gatifloxacin—Hyperhidrosis—Methotrexate—hematologic cancer	3.19e-05	8.63e-05	CcSEcCtD
Gatifloxacin—Vomiting—Triamcinolone—hematologic cancer	3.18e-05	8.59e-05	CcSEcCtD
Gatifloxacin—ALB—Folate Metabolism—CCL2—hematologic cancer	3.16e-05	0.00382	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—MPL—hematologic cancer	3.15e-05	0.00381	CbGpPWpGaD
Gatifloxacin—Rash—Triamcinolone—hematologic cancer	3.15e-05	8.52e-05	CcSEcCtD
Gatifloxacin—Dermatitis—Triamcinolone—hematologic cancer	3.15e-05	8.51e-05	CcSEcCtD
Gatifloxacin—Vertigo—Doxorubicin—hematologic cancer	3.15e-05	8.51e-05	CcSEcCtD
Gatifloxacin—Anorexia—Methotrexate—hematologic cancer	3.15e-05	8.51e-05	CcSEcCtD
Gatifloxacin—Syncope—Doxorubicin—hematologic cancer	3.14e-05	8.49e-05	CcSEcCtD
Gatifloxacin—Urticaria—Prednisone—hematologic cancer	3.14e-05	8.48e-05	CcSEcCtD
Gatifloxacin—Headache—Triamcinolone—hematologic cancer	3.13e-05	8.47e-05	CcSEcCtD
Gatifloxacin—Abdominal pain—Prednisone—hematologic cancer	3.12e-05	8.44e-05	CcSEcCtD
Gatifloxacin—Body temperature increased—Prednisone—hematologic cancer	3.12e-05	8.44e-05	CcSEcCtD
Gatifloxacin—Confusional state—Epirubicin—hematologic cancer	3.11e-05	8.42e-05	CcSEcCtD
Gatifloxacin—Diarrhoea—Dexamethasone—hematologic cancer	3.1e-05	8.39e-05	CcSEcCtD
Gatifloxacin—Diarrhoea—Betamethasone—hematologic cancer	3.1e-05	8.39e-05	CcSEcCtD
Gatifloxacin—Palpitations—Doxorubicin—hematologic cancer	3.1e-05	8.37e-05	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Epirubicin—hematologic cancer	3.09e-05	8.35e-05	CcSEcCtD
Gatifloxacin—Oedema—Epirubicin—hematologic cancer	3.09e-05	8.35e-05	CcSEcCtD
Gatifloxacin—Hypotension—Methotrexate—hematologic cancer	3.08e-05	8.34e-05	CcSEcCtD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—RAC2—hematologic cancer	3.08e-05	0.00373	CbGpPWpGaD
Gatifloxacin—Loss of consciousness—Doxorubicin—hematologic cancer	3.08e-05	8.32e-05	CcSEcCtD
Gatifloxacin—Infection—Epirubicin—hematologic cancer	3.07e-05	8.3e-05	CcSEcCtD
Gatifloxacin—ALB—Selenium Micronutrient Network—CRP—hematologic cancer	3.05e-05	0.00369	CbGpPWpGaD
Gatifloxacin—Shock—Epirubicin—hematologic cancer	3.04e-05	8.22e-05	CcSEcCtD
Gatifloxacin—ALB—Platelet degranulation—FN1—hematologic cancer	3.04e-05	0.00367	CbGpPWpGaD
Gatifloxacin—Convulsion—Doxorubicin—hematologic cancer	3.03e-05	8.21e-05	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Epirubicin—hematologic cancer	3.02e-05	8.18e-05	CcSEcCtD
Gatifloxacin—ALB—Hemostasis—S100A10—hematologic cancer	3.02e-05	0.00366	CbGpPWpGaD
Gatifloxacin—Hypertension—Doxorubicin—hematologic cancer	3.02e-05	8.18e-05	CcSEcCtD
Gatifloxacin—Tachycardia—Epirubicin—hematologic cancer	3.01e-05	8.15e-05	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Methotrexate—hematologic cancer	3.01e-05	8.13e-05	CcSEcCtD
Gatifloxacin—Dizziness—Betamethasone—hematologic cancer	3e-05	8.11e-05	CcSEcCtD
Gatifloxacin—Dizziness—Dexamethasone—hematologic cancer	3e-05	8.11e-05	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Epirubicin—hematologic cancer	2.99e-05	8.08e-05	CcSEcCtD
Gatifloxacin—Insomnia—Methotrexate—hematologic cancer	2.99e-05	8.07e-05	CcSEcCtD
Gatifloxacin—Myalgia—Doxorubicin—hematologic cancer	2.98e-05	8.06e-05	CcSEcCtD
Gatifloxacin—Chest pain—Doxorubicin—hematologic cancer	2.98e-05	8.06e-05	CcSEcCtD
Gatifloxacin—Arthralgia—Doxorubicin—hematologic cancer	2.98e-05	8.06e-05	CcSEcCtD
Gatifloxacin—Anxiety—Doxorubicin—hematologic cancer	2.97e-05	8.03e-05	CcSEcCtD
Gatifloxacin—Nausea—Triamcinolone—hematologic cancer	2.97e-05	8.03e-05	CcSEcCtD
Gatifloxacin—Paraesthesia—Methotrexate—hematologic cancer	2.96e-05	8.01e-05	CcSEcCtD
Gatifloxacin—Anorexia—Epirubicin—hematologic cancer	2.94e-05	7.96e-05	CcSEcCtD
Gatifloxacin—Dyspnoea—Methotrexate—hematologic cancer	2.94e-05	7.96e-05	CcSEcCtD
Gatifloxacin—ALB—Vitamin B12 Metabolism—IL1B—hematologic cancer	2.94e-05	0.00356	CbGpPWpGaD
Gatifloxacin—Somnolence—Methotrexate—hematologic cancer	2.93e-05	7.94e-05	CcSEcCtD
Gatifloxacin—ALB—Hemostasis—GATA2—hematologic cancer	2.91e-05	0.00352	CbGpPWpGaD
Gatifloxacin—Hypersensitivity—Prednisone—hematologic cancer	2.91e-05	7.87e-05	CcSEcCtD
Gatifloxacin—Dyspepsia—Methotrexate—hematologic cancer	2.91e-05	7.86e-05	CcSEcCtD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—FN1—hematologic cancer	2.89e-05	0.0035	CbGpPWpGaD
Gatifloxacin—Hypotension—Epirubicin—hematologic cancer	2.89e-05	7.81e-05	CcSEcCtD
Gatifloxacin—Vomiting—Betamethasone—hematologic cancer	2.88e-05	7.8e-05	CcSEcCtD
Gatifloxacin—Vomiting—Dexamethasone—hematologic cancer	2.88e-05	7.8e-05	CcSEcCtD
Gatifloxacin—Confusional state—Doxorubicin—hematologic cancer	2.88e-05	7.79e-05	CcSEcCtD
Gatifloxacin—Decreased appetite—Methotrexate—hematologic cancer	2.87e-05	7.76e-05	CcSEcCtD
Gatifloxacin—Rash—Dexamethasone—hematologic cancer	2.86e-05	7.73e-05	CcSEcCtD
Gatifloxacin—Rash—Betamethasone—hematologic cancer	2.86e-05	7.73e-05	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Doxorubicin—hematologic cancer	2.86e-05	7.73e-05	CcSEcCtD
Gatifloxacin—Oedema—Doxorubicin—hematologic cancer	2.86e-05	7.73e-05	CcSEcCtD
Gatifloxacin—Dermatitis—Betamethasone—hematologic cancer	2.86e-05	7.73e-05	CcSEcCtD
Gatifloxacin—Dermatitis—Dexamethasone—hematologic cancer	2.86e-05	7.73e-05	CcSEcCtD
Gatifloxacin—Headache—Dexamethasone—hematologic cancer	2.84e-05	7.68e-05	CcSEcCtD
Gatifloxacin—Headache—Betamethasone—hematologic cancer	2.84e-05	7.68e-05	CcSEcCtD
Gatifloxacin—Infection—Doxorubicin—hematologic cancer	2.84e-05	7.68e-05	CcSEcCtD
Gatifloxacin—Asthenia—Prednisone—hematologic cancer	2.83e-05	7.66e-05	CcSEcCtD
Gatifloxacin—ALB—SLC-mediated transmembrane transport—SLC22A1—hematologic cancer	2.82e-05	0.00341	CbGpPWpGaD
Gatifloxacin—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.81e-05	7.61e-05	CcSEcCtD
Gatifloxacin—Shock—Doxorubicin—hematologic cancer	2.81e-05	7.6e-05	CcSEcCtD
Gatifloxacin—ALB—Selenium Micronutrient Network—ICAM1—hematologic cancer	2.8e-05	0.00339	CbGpPWpGaD
Gatifloxacin—Thrombocytopenia—Doxorubicin—hematologic cancer	2.8e-05	7.57e-05	CcSEcCtD
Gatifloxacin—Pruritus—Prednisone—hematologic cancer	2.79e-05	7.56e-05	CcSEcCtD
Gatifloxacin—Insomnia—Epirubicin—hematologic cancer	2.79e-05	7.56e-05	CcSEcCtD
Gatifloxacin—Tachycardia—Doxorubicin—hematologic cancer	2.79e-05	7.54e-05	CcSEcCtD
Gatifloxacin—Paraesthesia—Epirubicin—hematologic cancer	2.77e-05	7.5e-05	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Doxorubicin—hematologic cancer	2.76e-05	7.47e-05	CcSEcCtD
Gatifloxacin—Dyspnoea—Epirubicin—hematologic cancer	2.75e-05	7.45e-05	CcSEcCtD
Gatifloxacin—Somnolence—Epirubicin—hematologic cancer	2.75e-05	7.43e-05	CcSEcCtD
Gatifloxacin—Anorexia—Doxorubicin—hematologic cancer	2.72e-05	7.37e-05	CcSEcCtD
Gatifloxacin—Feeling abnormal—Methotrexate—hematologic cancer	2.72e-05	7.36e-05	CcSEcCtD
Gatifloxacin—Dyspepsia—Epirubicin—hematologic cancer	2.72e-05	7.35e-05	CcSEcCtD
Gatifloxacin—Diarrhoea—Prednisone—hematologic cancer	2.7e-05	7.31e-05	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Methotrexate—hematologic cancer	2.7e-05	7.3e-05	CcSEcCtD
Gatifloxacin—Nausea—Betamethasone—hematologic cancer	2.69e-05	7.28e-05	CcSEcCtD
Gatifloxacin—Nausea—Dexamethasone—hematologic cancer	2.69e-05	7.28e-05	CcSEcCtD
Gatifloxacin—Decreased appetite—Epirubicin—hematologic cancer	2.69e-05	7.26e-05	CcSEcCtD
Gatifloxacin—ALB—Folate Metabolism—IFNG—hematologic cancer	2.68e-05	0.00325	CbGpPWpGaD
Gatifloxacin—Hypotension—Doxorubicin—hematologic cancer	2.67e-05	7.22e-05	CcSEcCtD
Gatifloxacin—ALB—SLC-mediated transmembrane transport—NUP98—hematologic cancer	2.66e-05	0.00322	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—SPARC—hematologic cancer	2.66e-05	0.00322	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—ATP1B1—hematologic cancer	2.64e-05	0.0032	CbGpPWpGaD
Gatifloxacin—Constipation—Epirubicin—hematologic cancer	2.64e-05	7.14e-05	CcSEcCtD
Gatifloxacin—Urticaria—Methotrexate—hematologic cancer	2.62e-05	7.09e-05	CcSEcCtD
Gatifloxacin—ALB—Transmembrane transport of small molecules—S100A10—hematologic cancer	2.62e-05	0.00317	CbGpPWpGaD
Gatifloxacin—Dizziness—Prednisone—hematologic cancer	2.61e-05	7.06e-05	CcSEcCtD
Gatifloxacin—Abdominal pain—Methotrexate—hematologic cancer	2.61e-05	7.06e-05	CcSEcCtD
Gatifloxacin—Body temperature increased—Methotrexate—hematologic cancer	2.61e-05	7.06e-05	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.6e-05	7.04e-05	CcSEcCtD
Gatifloxacin—Insomnia—Doxorubicin—hematologic cancer	2.59e-05	6.99e-05	CcSEcCtD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—LCK—hematologic cancer	2.58e-05	0.00312	CbGpPWpGaD
Gatifloxacin—ALB—SLC-mediated transmembrane transport—NUP214—hematologic cancer	2.57e-05	0.0031	CbGpPWpGaD
Gatifloxacin—Paraesthesia—Doxorubicin—hematologic cancer	2.57e-05	6.94e-05	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—GBA—hematologic cancer	2.56e-05	0.00309	CbGpPWpGaD
Gatifloxacin—Dyspnoea—Doxorubicin—hematologic cancer	2.55e-05	6.89e-05	CcSEcCtD
Gatifloxacin—Feeling abnormal—Epirubicin—hematologic cancer	2.55e-05	6.88e-05	CcSEcCtD
Gatifloxacin—Somnolence—Doxorubicin—hematologic cancer	2.54e-05	6.87e-05	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Epirubicin—hematologic cancer	2.53e-05	6.83e-05	CcSEcCtD
Gatifloxacin—Dyspepsia—Doxorubicin—hematologic cancer	2.52e-05	6.8e-05	CcSEcCtD
Gatifloxacin—Vomiting—Prednisone—hematologic cancer	2.51e-05	6.79e-05	CcSEcCtD
Gatifloxacin—ALB—Selenium Micronutrient Network—CCL2—hematologic cancer	2.51e-05	0.00303	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—GATA1—hematologic cancer	2.51e-05	0.00303	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—HSPA5—hematologic cancer	2.49e-05	0.00301	CbGpPWpGaD
Gatifloxacin—Rash—Prednisone—hematologic cancer	2.49e-05	6.73e-05	CcSEcCtD
Gatifloxacin—Dermatitis—Prednisone—hematologic cancer	2.49e-05	6.73e-05	CcSEcCtD
Gatifloxacin—Decreased appetite—Doxorubicin—hematologic cancer	2.48e-05	6.72e-05	CcSEcCtD
Gatifloxacin—Headache—Prednisone—hematologic cancer	2.47e-05	6.69e-05	CcSEcCtD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—PRKCZ—hematologic cancer	2.46e-05	0.00297	CbGpPWpGaD
Gatifloxacin—Urticaria—Epirubicin—hematologic cancer	2.45e-05	6.64e-05	CcSEcCtD
Gatifloxacin—Constipation—Doxorubicin—hematologic cancer	2.44e-05	6.61e-05	CcSEcCtD
Gatifloxacin—Abdominal pain—Epirubicin—hematologic cancer	2.44e-05	6.6e-05	CcSEcCtD
Gatifloxacin—Body temperature increased—Epirubicin—hematologic cancer	2.44e-05	6.6e-05	CcSEcCtD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	2.43e-05	0.00294	CbGpPWpGaD
Gatifloxacin—Hypersensitivity—Methotrexate—hematologic cancer	2.43e-05	6.58e-05	CcSEcCtD
Gatifloxacin—ALB—Folate Metabolism—IL1B—hematologic cancer	2.39e-05	0.00289	CbGpPWpGaD
Gatifloxacin—ALB—Folate Metabolism—IL2—hematologic cancer	2.39e-05	0.00288	CbGpPWpGaD
Gatifloxacin—Asthenia—Methotrexate—hematologic cancer	2.37e-05	6.4e-05	CcSEcCtD
Gatifloxacin—Feeling abnormal—Doxorubicin—hematologic cancer	2.36e-05	6.37e-05	CcSEcCtD
Gatifloxacin—Nausea—Prednisone—hematologic cancer	2.35e-05	6.34e-05	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.34e-05	6.32e-05	CcSEcCtD
Gatifloxacin—Pruritus—Methotrexate—hematologic cancer	2.34e-05	6.31e-05	CcSEcCtD
Gatifloxacin—ALB—Hemostasis—ANXA2—hematologic cancer	2.29e-05	0.00277	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	2.29e-05	0.00277	CbGpPWpGaD
Gatifloxacin—Hypersensitivity—Epirubicin—hematologic cancer	2.28e-05	6.15e-05	CcSEcCtD
Gatifloxacin—Urticaria—Doxorubicin—hematologic cancer	2.27e-05	6.14e-05	CcSEcCtD
Gatifloxacin—Abdominal pain—Doxorubicin—hematologic cancer	2.26e-05	6.11e-05	CcSEcCtD
Gatifloxacin—Body temperature increased—Doxorubicin—hematologic cancer	2.26e-05	6.11e-05	CcSEcCtD
Gatifloxacin—Diarrhoea—Methotrexate—hematologic cancer	2.26e-05	6.11e-05	CcSEcCtD
Gatifloxacin—Asthenia—Epirubicin—hematologic cancer	2.22e-05	5.99e-05	CcSEcCtD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—IL3—hematologic cancer	2.21e-05	0.00267	CbGpPWpGaD
Gatifloxacin—Pruritus—Epirubicin—hematologic cancer	2.19e-05	5.91e-05	CcSEcCtD
Gatifloxacin—Dizziness—Methotrexate—hematologic cancer	2.18e-05	5.9e-05	CcSEcCtD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—PTPN1—hematologic cancer	2.17e-05	0.00263	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	2.17e-05	0.00262	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—RASGRP1—hematologic cancer	2.14e-05	0.00258	CbGpPWpGaD
Gatifloxacin—ALB—Vitamin B12 Metabolism—TNF—hematologic cancer	2.14e-05	0.00258	CbGpPWpGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—IFNG—hematologic cancer	2.13e-05	0.00258	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—GNA13—hematologic cancer	2.13e-05	0.00258	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—SYK—hematologic cancer	2.13e-05	0.00257	CbGpPWpGaD
Gatifloxacin—Diarrhoea—Epirubicin—hematologic cancer	2.11e-05	5.72e-05	CcSEcCtD
Gatifloxacin—Hypersensitivity—Doxorubicin—hematologic cancer	2.11e-05	5.69e-05	CcSEcCtD
Gatifloxacin—Vomiting—Methotrexate—hematologic cancer	2.1e-05	5.68e-05	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	2.09e-05	0.00252	CbGpPWpGaD
Gatifloxacin—Rash—Methotrexate—hematologic cancer	2.08e-05	5.63e-05	CcSEcCtD
Gatifloxacin—Dermatitis—Methotrexate—hematologic cancer	2.08e-05	5.62e-05	CcSEcCtD
Gatifloxacin—Headache—Methotrexate—hematologic cancer	2.07e-05	5.59e-05	CcSEcCtD
Gatifloxacin—Asthenia—Doxorubicin—hematologic cancer	2.05e-05	5.55e-05	CcSEcCtD
Gatifloxacin—Dizziness—Epirubicin—hematologic cancer	2.04e-05	5.52e-05	CcSEcCtD
Gatifloxacin—ALB—Hemostasis—JAK3—hematologic cancer	2.03e-05	0.00246	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—ITGAX—hematologic cancer	2.03e-05	0.00246	CbGpPWpGaD
Gatifloxacin—Pruritus—Doxorubicin—hematologic cancer	2.02e-05	5.47e-05	CcSEcCtD
Gatifloxacin—ALB—Hemostasis—CD9—hematologic cancer	2e-05	0.00242	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—F3—hematologic cancer	2e-05	0.00242	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SGK1—hematologic cancer	1.98e-05	0.0024	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—ATP4A—hematologic cancer	1.98e-05	0.0024	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—ANXA2—hematologic cancer	1.98e-05	0.0024	CbGpPWpGaD
Gatifloxacin—Vomiting—Epirubicin—hematologic cancer	1.96e-05	5.31e-05	CcSEcCtD
Gatifloxacin—Nausea—Methotrexate—hematologic cancer	1.96e-05	5.3e-05	CcSEcCtD
Gatifloxacin—Diarrhoea—Doxorubicin—hematologic cancer	1.96e-05	5.29e-05	CcSEcCtD
Gatifloxacin—ALB—Hemostasis—SELL—hematologic cancer	1.95e-05	0.00236	CbGpPWpGaD
Gatifloxacin—Rash—Epirubicin—hematologic cancer	1.95e-05	5.27e-05	CcSEcCtD
Gatifloxacin—Dermatitis—Epirubicin—hematologic cancer	1.95e-05	5.26e-05	CcSEcCtD
Gatifloxacin—Headache—Epirubicin—hematologic cancer	1.94e-05	5.23e-05	CcSEcCtD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—GRB2—hematologic cancer	1.92e-05	0.00232	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—PDGFA—hematologic cancer	1.92e-05	0.00232	CbGpPWpGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—IL1B—hematologic cancer	1.9e-05	0.0023	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—IL3RA—hematologic cancer	1.9e-05	0.0023	CbGpPWpGaD
Gatifloxacin—Dizziness—Doxorubicin—hematologic cancer	1.89e-05	5.11e-05	CcSEcCtD
Gatifloxacin—Nausea—Epirubicin—hematologic cancer	1.83e-05	4.96e-05	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	1.82e-05	0.00221	CbGpPWpGaD
Gatifloxacin—Vomiting—Doxorubicin—hematologic cancer	1.82e-05	4.91e-05	CcSEcCtD
Gatifloxacin—Rash—Doxorubicin—hematologic cancer	1.8e-05	4.87e-05	CcSEcCtD
Gatifloxacin—Dermatitis—Doxorubicin—hematologic cancer	1.8e-05	4.87e-05	CcSEcCtD
Gatifloxacin—Headache—Doxorubicin—hematologic cancer	1.79e-05	4.84e-05	CcSEcCtD
Gatifloxacin—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—hematologic cancer	1.79e-05	0.00216	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	1.79e-05	0.00216	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GMPS—hematologic cancer	1.77e-05	0.00214	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—FTCD—hematologic cancer	1.77e-05	0.00214	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PHYH—hematologic cancer	1.77e-05	0.00214	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	1.75e-05	0.00212	CbGpPWpGaD
Gatifloxacin—ALB—Platelet degranulation—VEGFA—hematologic cancer	1.74e-05	0.0021	CbGpPWpGaD
Gatifloxacin—ALB—Folate Metabolism—TNF—hematologic cancer	1.74e-05	0.0021	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—H3F3B—hematologic cancer	1.74e-05	0.0021	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—FGR—hematologic cancer	1.74e-05	0.0021	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—HGF—hematologic cancer	1.74e-05	0.0021	CbGpPWpGaD
Gatifloxacin—ALB—Vitamin B12 Metabolism—IL6—hematologic cancer	1.72e-05	0.00208	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—CSF2—hematologic cancer	1.72e-05	0.00208	CbGpPWpGaD
Gatifloxacin—Nausea—Doxorubicin—hematologic cancer	1.7e-05	4.59e-05	CcSEcCtD
Gatifloxacin—ALB—Hemostasis—ITGAL—hematologic cancer	1.67e-05	0.00202	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—MYB—hematologic cancer	1.67e-05	0.00202	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	1.67e-05	0.00202	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—JAK1—hematologic cancer	1.66e-05	0.002	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—PRKCG—hematologic cancer	1.66e-05	0.002	CbGpPWpGaD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—hematologic cancer	1.66e-05	0.002	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	1.65e-05	0.00199	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—SMPD3—hematologic cancer	1.62e-05	0.00196	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	1.61e-05	0.00195	CbGpPWpGaD
Gatifloxacin—ALB—Platelet degranulation—TGFB1—hematologic cancer	1.6e-05	0.00193	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—RAC2—hematologic cancer	1.59e-05	0.00192	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—ABCC3—hematologic cancer	1.57e-05	0.0019	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—IL2RA—hematologic cancer	1.55e-05	0.00187	CbGpPWpGaD
Gatifloxacin—ALB—Folate Metabolism—TP53—hematologic cancer	1.53e-05	0.00185	CbGpPWpGaD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—hematologic cancer	1.52e-05	0.00184	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	1.51e-05	0.00182	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—PDGFB—hematologic cancer	1.49e-05	0.00181	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	1.47e-05	0.00178	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—SH2B3—hematologic cancer	1.44e-05	0.00174	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	1.43e-05	0.00173	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—B3GAT1—hematologic cancer	1.41e-05	0.00171	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ASNS—hematologic cancer	1.41e-05	0.00171	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—DCK—hematologic cancer	1.41e-05	0.00171	CbGpPWpGaD
Gatifloxacin—ALB—Folate Metabolism—IL6—hematologic cancer	1.4e-05	0.0017	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—MAPK14—hematologic cancer	1.39e-05	0.00168	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	1.38e-05	0.00167	CbGpPWpGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—TNF—hematologic cancer	1.38e-05	0.00167	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—SPARC—hematologic cancer	1.37e-05	0.00166	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—NUP98—hematologic cancer	1.35e-05	0.00164	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—FN1—hematologic cancer	1.35e-05	0.00163	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—HDC—hematologic cancer	1.34e-05	0.00162	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—LCK—hematologic cancer	1.33e-05	0.00161	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—ADCY7—hematologic cancer	1.31e-05	0.00159	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—NUP214—hematologic cancer	1.3e-05	0.00158	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—H3F3A—hematologic cancer	1.3e-05	0.00158	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—GATA3—hematologic cancer	1.29e-05	0.00156	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—PIK3CG—hematologic cancer	1.29e-05	0.00156	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—HSPA5—hematologic cancer	1.28e-05	0.00155	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—ABCG2—hematologic cancer	1.28e-05	0.00155	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PRKCZ—hematologic cancer	1.27e-05	0.00153	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1.25e-05	0.00151	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CDA—hematologic cancer	1.23e-05	0.00148	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—HDAC2—hematologic cancer	1.18e-05	0.00143	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PC—hematologic cancer	1.18e-05	0.00143	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—ITGA4—hematologic cancer	1.17e-05	0.00141	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—CD44—hematologic cancer	1.17e-05	0.00141	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GBA—hematologic cancer	1.14e-05	0.00138	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—SLC35B2—hematologic cancer	1.14e-05	0.00138	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.14e-05	0.00138	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—IL3—hematologic cancer	1.14e-05	0.00138	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—PIK3CD—hematologic cancer	1.13e-05	0.00137	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—IFNA1—hematologic cancer	1.13e-05	0.00137	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PTPN1—hematologic cancer	1.12e-05	0.00135	CbGpPWpGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—IL6—hematologic cancer	1.11e-05	0.00135	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—RASGRP1—hematologic cancer	1.1e-05	0.00133	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—SYK—hematologic cancer	1.1e-05	0.00133	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—PIK3R1—hematologic cancer	1.07e-05	0.00129	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—IFNA2—hematologic cancer	1.05e-05	0.00127	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—MTAP—hematologic cancer	1.04e-05	0.00126	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—JAK2—hematologic cancer	1.04e-05	0.00126	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—GRB2—hematologic cancer	9.9e-06	0.0012	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PDGFA—hematologic cancer	9.88e-06	0.00119	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—PIK3CB—hematologic cancer	9.88e-06	0.00119	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—CYCS—hematologic cancer	9.56e-06	0.00116	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—ABL1—hematologic cancer	9.52e-06	0.00115	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—FHL2—hematologic cancer	9.29e-06	0.00112	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—AGRN—hematologic cancer	9.11e-06	0.0011	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—IL2—hematologic cancer	9.07e-06	0.0011	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—HGF—hematologic cancer	8.95e-06	0.00108	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—CSF2—hematologic cancer	8.85e-06	0.00107	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—IDH2—hematologic cancer	8.64e-06	0.00104	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—HMMR—hematologic cancer	8.64e-06	0.00104	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PRKCG—hematologic cancer	8.54e-06	0.00103	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—JAK1—hematologic cancer	8.54e-06	0.00103	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	8.15e-06	0.000985	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ARNTL—hematologic cancer	8.12e-06	0.000982	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—ABCB1—hematologic cancer	7.98e-06	0.000965	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—IL2RA—hematologic cancer	7.98e-06	0.000964	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—SRC—hematologic cancer	7.91e-06	0.000957	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ACP5—hematologic cancer	7.9e-06	0.000955	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CA9—hematologic cancer	7.9e-06	0.000955	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—NCOR2—hematologic cancer	7.8e-06	0.000943	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—VEGFA—hematologic cancer	7.71e-06	0.000932	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PDGFB—hematologic cancer	7.7e-06	0.000931	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—CDK2—hematologic cancer	7.47e-06	0.000903	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—IDH1—hematologic cancer	7.43e-06	0.000898	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ABCC3—hematologic cancer	7.35e-06	0.000888	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—TXN—hematologic cancer	7.35e-06	0.000888	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GSTO1—hematologic cancer	7.35e-06	0.000888	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—MAPK3—hematologic cancer	7.29e-06	0.000882	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—SPHK1—hematologic cancer	7.19e-06	0.000869	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—MAPK14—hematologic cancer	7.16e-06	0.000866	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—TGFB1—hematologic cancer	7.08e-06	0.000855	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—FN1—hematologic cancer	6.94e-06	0.000839	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—UGT1A1—hematologic cancer	6.91e-06	0.000835	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CRABP1—hematologic cancer	6.72e-06	0.000812	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—SLC22A1—hematologic cancer	6.72e-06	0.000812	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PIK3CG—hematologic cancer	6.64e-06	0.000803	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ALOX5—hematologic cancer	6.55e-06	0.000792	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PTPN11—hematologic cancer	6.53e-06	0.000789	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—NUP98—hematologic cancer	6.34e-06	0.000767	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—CREBBP—hematologic cancer	6.16e-06	0.000745	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—NCOA3—hematologic cancer	6.16e-06	0.000744	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ADCY7—hematologic cancer	6.16e-06	0.000744	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—NUP214—hematologic cancer	6.11e-06	0.000739	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.05e-06	0.000731	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—PIK3CA—hematologic cancer	6.02e-06	0.000728	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ABCG2—hematologic cancer	5.99e-06	0.000724	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—MTR—hematologic cancer	5.99e-06	0.000724	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ENO2—hematologic cancer	5.87e-06	0.00071	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PIK3CD—hematologic cancer	5.84e-06	0.000706	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GSTT1—hematologic cancer	5.7e-06	0.000689	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.61e-06	0.000678	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—SDC1—hematologic cancer	5.57e-06	0.000673	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PIK3R1—hematologic cancer	5.52e-06	0.000667	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—JAK2—hematologic cancer	5.36e-06	0.000648	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5.33e-06	0.000645	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.32e-06	0.000643	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PIK3CB—hematologic cancer	5.09e-06	0.000616	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.02e-06	0.000607	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	4.92e-06	0.000595	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—NQO1—hematologic cancer	4.73e-06	0.000572	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CD44—hematologic cancer	4.73e-06	0.000572	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—IL2—hematologic cancer	4.68e-06	0.000565	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.63e-06	0.00056	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CYCS—hematologic cancer	4.48e-06	0.000542	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—HSP90AA1—hematologic cancer	4.45e-06	0.000538	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—EP300—hematologic cancer	4.2e-06	0.000507	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—SRC—hematologic cancer	4.08e-06	0.000493	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.01e-06	0.000484	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—VEGFA—hematologic cancer	3.97e-06	0.00048	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GSTP1—hematologic cancer	3.95e-06	0.000477	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—NRAS—hematologic cancer	3.92e-06	0.000475	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.82e-06	0.000462	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—MAPK3—hematologic cancer	3.76e-06	0.000454	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ABCB1—hematologic cancer	3.74e-06	0.000452	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—TGFB1—hematologic cancer	3.65e-06	0.000441	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GSTM1—hematologic cancer	3.63e-06	0.000439	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—NCOR1—hematologic cancer	3.63e-06	0.000439	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—KRAS—hematologic cancer	3.38e-06	0.000408	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—MTHFR—hematologic cancer	3.21e-06	0.000388	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PIK3CA—hematologic cancer	3.1e-06	0.000375	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—TP53—hematologic cancer	3e-06	0.000363	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—HRAS—hematologic cancer	2.87e-06	0.000347	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.83e-06	0.000342	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PIK3CG—hematologic cancer	2.69e-06	0.000326	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—AKT1—hematologic cancer	2.54e-06	0.000307	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CREBBP—hematologic cancer	2.5e-06	0.000302	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PIK3CD—hematologic cancer	2.37e-06	0.000286	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PIK3R1—hematologic cancer	2.24e-06	0.00027	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PIK3CB—hematologic cancer	2.06e-06	0.00025	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PTEN—hematologic cancer	1.78e-06	0.000216	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—EP300—hematologic cancer	1.7e-06	0.000206	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PIK3CA—hematologic cancer	1.26e-06	0.000152	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—AKT1—hematologic cancer	1.03e-06	0.000124	CbGpPWpGaD
